TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 200 participants.

Also called NCT07721129

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Oman Ministry of Health (from the registry)
Registry
  • NCT NCT07721129
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07721129. Non-randomized; single masking; primary purpose treatment. Start 2026-08-01 (anticipated); primary completion 2026-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TeleStroke-Guided Thrombolysis for Acute Ischemic Stroke in Oman
Condition
Ischemic Stroke, Acute
Condition
Ischemic Stroke
Intervention (Drug)
alteplase or tenecteplase
Lead sponsor
Oman Ministry of Health (class: other government)
Collaborator
Sultan Qaboos University (class: other)

Record details

Record id
cardio:ct-nct07721129
Content hash
72e49c444309f59f02cd0beaf5e6508c329b7df363bdf3c631571a4cd45bee92